Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Since its establishment with great dedication and effort in 1975, the first and the most important goal of our company has been contributing to public health and the pharmaceutical industry. We have always endeavoured to achieve the better and the favourable by using the strength taken from our sector for the benefit of the sector. Our mission as Drogsan Pharmaceuticals, is being a leading organization, which keeps its priority on human health, its efficiency and effectiveness at the top level, grows with continuous improvement, operates under moral and ethical values, and whose employees are proud to be a part of. We institutionalized our production and service infrastructure, with our vision to be a pharmaceutical company that is well-known, esteemed, followed and permanent on both local and international platforms.
As a company that works for creating value in health, we are conscious of fulfilling our duties and responsibilities against our public, physicians, pharmacists, customers, suppliers and employees at our best in all circumstances. We aim to be an institution following the latest developments in the health sector which has been changing at a dizzying speed, adapting to the innovations, and converting this process of change into a build-up and growth energy.
By synthesizing with industrial innovations, we will keep on transforming the experience we gained in the past years into the best quality products and services for the use of our public, physicians, pharmacists, and all health sector stakeholders in the coming years. Because for us, “respect to health” means first and foremost…
Contact
Dilmenler Cad. Aslanoba Plaza No: 19/7A Mahmut Bey Mah.
34218 Bağcılar – İSTANBUL
Phone: + 90 (0212) 445 06 00
Fax: + 90 (0212) 445 06 16
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Avinash Potnis of Novartis Turkey discusses potential solutions to the country’s access and pricing dilemma which has raised concerns of system sustainability. Potnis also highlights the strengths of Turkey’s healthcare…
Ingrid Drechsel, head of Bayer’s pharma operations in Turkey and Iran, discusses the complexity of managing two countries under economic pressure and the advantages of Bayer’s longstanding relationship in both…
Menarini’s general manager for Turkey, the Middle East and Africa Uğur Bingöl discusses the Italian company’s restructuring in the region and its desire to replicate its success in Turkey across…
The secretary general for Turkey’s Pharmaceutical Manufacturers Association (IEIS), Savaş Malkoç, highlights their objective of increasing R&D expenditure and Turkey’s big opportunity ahead in biosimilars production. In addition, Malkoç discusses…
Janssen’s Managing Director for Turkey, Demet Russ, discusses her return to the country after 25 years abroad, having worked for Johnson & Johnson in different local, regional and global roles…
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp Haas discusses the…
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took off. After just a few months, it became apparent that people with…
The president of the Turkish Society of Cardiology, Mustafa Kemal Erol, discusses the prevalence of cardiovascular disease, which accounts for over a third of deaths in Turkey, the improvements made…
AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with over USD 50 billion in investment, their help during the pandemic, the chamber’s…
Dr Burak Cem, Novo Nordisk Vice President and General Manager for Turkey, outlines the company’s big bet on Turkey as a future regional hub through deep investment in clinical trials,…
Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over the past decades, comparing the improvements to the difference between a Ford Model T to a…
See our Cookie Privacy Policy Here
